Avita Medical | 1811094D - Market Capitalization


Avita Medical reported AUD496.42M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nanosonics AUD 1.2B 25.43M Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pacific Edge NZD 177.94M 16.27M Jun/2026
Pharma Mar EUR 1.31B 263.2M Jun/2026
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Qiagen NV USD 8.07B 197.36M Jun/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 47.56B 4.96B Mar/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Telix Pharmaceuticals AUD 7.81B 2.74B Jun/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026